Oleanolic acid bioavailability in human serum
[Description of methods used for collection/generation of data] 1. Extraction and GC-MS determination (DOI 10.1002/bmc.3480); 2. UV Spectrophotometry method for OA-HSA association (DOI 10.1021/jf1039537); 3. Enzymatic methods were used to determine serum glucose, total cholesterol, HDL and triglycer...
| Autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | conjunto de datos |
| Fecha de publicación: | 2023 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/335582 |
| Acceso en línea: | http://hdl.handle.net/10261/335582 https://doi.org/10.20350/digitalCSIC/15571 |
| Access Level: | acceso abierto |
| Palabra clave: | Oleanolic acid Bioavailability in humans Pharmacokinetics NCT05529953 Postprandial trial Human serum proteins Human triglyceride-rich lipoproteins |
| Sumario: | [Description of methods used for collection/generation of data] 1. Extraction and GC-MS determination (DOI 10.1002/bmc.3480); 2. UV Spectrophotometry method for OA-HSA association (DOI 10.1021/jf1039537); 3. Enzymatic methods were used to determine serum glucose, total cholesterol, HDL and triglycerides, whereas LDL was estimated by the Friedewald formula (14). Total lipoprotein Apo B (Apo B48 + Apo B100) was quantified by an immunoturbidimetric assay (Tinaquant; Roche Diagnostics, Mannheim, Germany), and serum insulin using an ELISA kit (Diaclone, Besançon, France). |
|---|